Background: Ambulatory 24-h pulse pressure predicts progression of albuminuria in people with diabetes mellitus. It is not known whether the ambulatory arterial stiffness index (AASI) may add to that prediction.
A lbuminuria is an independent predictor of cardiovascular morbidity and mortality in people with and without diabetes mellitus. [1] [2] [3] [4] The association of albumin urinary excretion with major cardiac events extends to urine albumin levels below the currently accepted, arbitrary cutoff point for microalbuminuria. 5, 6 Increments in the albumin urinary excretion also appear to be associated with increased cardiovascular morbidity and mortality. 7 Conversely, a decrease in albuminuria through drug treatment has been shown to improve both cardio-vascular and renal outcomes. 8 Albuminuria is prevalent in elderly and middle-aged people with type 2 diabetes mellitus, and is often present when diabetes is diagnosed. 9 -11 Thus, it is important to identify predictors of worsening albuminuria in elderly people with diabetes mellitus.
In people with diabetes mellitus, ambulatory blood pressure monitoring (ABPM) has been shown to predict progression of albuminuria above and beyond office blood pressure (BP). [12] [13] [14] [15] Pulse pressure is of particular interest in the elderly because it is a measure of the increased arterial stiffness found in that age group. We previously reported that 24-h pulse pressure from ABPM outperforms office pulse pressure in predicting progression of albuminuria in elderly patients with diabetes. 15 In addition to 24-h pulse pressure, recent publications have proposed the ambulatory arterial stiffness index (AASI) as a novel method to estimate arterial stiffness using ABPM. 16, 17 The AASI is inversely related to the variability of diastolic BP as a function of systolic BP during monitoring. For example, in the elderly, diastolic BP varies less for a given amount of change in systolic BP, resulting in a higher AASI-this loss of correlated variability has been attributed to increased arterial stiffness. 16, 17 In a recent study AASI was an independent predictor of cardiovascular mortality, performing better than 24-h pulse pressure in predicting fatal strokes. 18 Regarding albuminuria, a cross-sectional association between AASI and albuminuria has been reported in hypertensive subjects after adjustment for multiple covariates, including 24-h systolic BP. 19 However, it is not known whether AASI is an independent predictor of the progression of albuminuria, and, if so, whether it adds to the information provided by 24-h pulse pressure. Therefore, we assessed the multivariate-adjusted association of baseline AASI and 24-h pulse pressure with progression of albuminuria during 3 years of follow-up in a well-characterized, multiethnic cohort of elderly patients with diabetes. Our goal was to assess the comparative value of AASI and 24-h pulse pressure to predict progression of albuminuria when added to a clinical evaluation that included office BP measurements.
Methods

Data Collection
We studied participants enrolled in the Informatics for Diabetes Education and Telemedicine (IDEATel) study, which has been described in detail elsewhere. 20 IDEATel evaluates telemedicine as a means of managing the care of older Medicare beneficiaries (aged 55 years and older) with diabetes who reside in medically underserved areas of New York State. Inclusion criteria in IDEATel were: age Ͼ55 years, being a current Medicare beneficiary, having diabetes as defined by a physician's diagnosis and being on treatment with diet, an oral hypoglycemic agent, or insulin, residence in a federally designated medically underserved area (either of two federal designations, Medically Underserved Area [MUA] or Health Professional Shortage Area [HPSA]) in New York State, and fluency in either English or Spanish. Exclusion criteria were: moderate or severe cognitive impairment, severe visual, mobility, or motor coordination impairment, severe comorbid condition, severe expressive or receptive communication impairment, lack of free electrical outlet for home telemedicine unit, and spending more than 3 months a year at a location different from their New York State residence. Participants were randomly assigned to: (1) continue their usual care or (2) receive a telemedicine diabetes case management intervention. All IDEATel participants signed informed consent, and the protocol was approved by the Institutional Review Boards at all participating institutions.
This study examined the relationship between data obtained at the baseline IDEATel examination, conducted during the years 2000 and 2001, and the urinary albumin content, measured by spot urine albumin-to-creatinine ratio, at three consecutive annual follow-up visits. Prescription drug use was ascertained by interviewer-administered questionnaire and confirmed through review of medication bottles. Medication use was successfully ascertained in 99.5% of the participants at the baseline visit. Height, weight, and seated BP were measured, blood and spot urine samples were collected, and 24-h ABPM was performed. Participants returned for follow-up examinations annually for up to 3 years after their baseline visit, and urine samples were collected at each visit.
Laboratory Measures
Urine albumin level was measured using the immunoprecipitin method (Diasorin, Stillwater, MN) from a random spot samples. Values Ͻ5.7 mg/dL were assigned a value of 4.0 mg/dL. Urine creatinine level was measured using the picric acid colorimetric method. Both analyses were performed using a Roche/Hitachi 717 automated analyzer (Roche Diagnostics, Indianapolis, IN). Hemoglobin A 1c was analyzed by boronate affinity chromatography with the Primus CLC 385 (Primus, Kansas City, MO). Total cholesterol, triglyceride, and HDL cholesterol levels were measured using enzymatic colorimetric methods (Vitros; Johnson & Johnson, New Brunswick, NJ). Biochemical analyses were performed at Penn Medical Laboratory (currently MedStar, Inc.) in Washington, DC.
Albumin-to-Creatinine Ratio
Albumin-to-creatinine ratio (ACR, milligrams of albumin per grams of creatinine) was calculated from a morning spot urine sample. Urine albumin excretion was categorized into normoalbuminuria (ACR Ͻ17 in men, and Ͻ25 in women), microalbuminuria (ACR 17 to 250 in men, and 25 to 355 in women), and macroalbuminuria (ACR Ͼ250 in men, and Ͼ355 in women); these thresholds are believed to identify people with a urinary albumin excretion Ͼ30 mg/24 h, and Ͼ300 mg/24 h, respectively. 21 In participants without macroalbuminuria at baseline, progression of albuminuria was defined as follows. In those with normoalbuminuria at baseline, progression was defined as microalbuminuria or macroalbuminuria in at least one follow-up measurement. In those with microalbuminuria at baseline, progression was defined as macroalbuminuria in at least one follow-up measurement.
In participants with either microalbuminuria or macroalbuminuria at baseline, improvement in albuminuria was defined as having a measurement within a lower albuminuria category at a follow-up visit, provided that it did not revert to a higher category in a subsequent measurement.
Resting BP Measurement
Resting BP was measured at the baseline and follow-up visits by trained and certified research personnel using the Dinamap Monitor Pro 100 (Critikon, Tampa, FL) automated oscillometric device. Three measurements were obtained in a seated position after 5 min of rest in a quiet room, using a standardized protocol. 22 The average of the second and third measurements was recorded as the resting BP.
Ambulatory BP Monitoring
Ambulatory BP monitoring was performed at the IDEATel baseline visit using a Spacelabs 90207 oscillometric monitor (SpaceLabs, Redmond, WA), following a published protocol. 23 Blood pressure was recorded every 20 min for a 24-h period with the machine programmed to deflate in 8-mm Hg bleed steps. Sleep and wake intervals were defined based on diary entries, and confirmed by a telephone interview on the morning when monitoring ended. Nocturnal dipping was defined as a ratio of mean sleepto-mean wake systolic BP of 0.80 to 0.90, inclusive (a decrease in sleep systolic BP of 10% to 20% relative to wake systolic BP). Nondipping was defined as a ratio Ͼ0.9, and extreme dipping was defined as a ratio Ͻ0.8.
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The AASI was calculated from unedited recordings as follows: (1) the regression of diastolic on systolic BP was fitted for each participant (not forcing the regression line through zero) and (2) AASI ϭ (1 Ϫ regression slope).
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Statistical Analysis
Variables that did not approximate a normal distribution, including ACR, were log transformed for the analyses. Comparisons of baseline characteristics across quartiles of AASI were made using 2 or Fisher's exact tests (when any expected cell frequency was Ͻ5) for categorical variables and ANOVA for continuous variables. Pearson correlation coefficients were calculated to assess the correlation between AASI and other BP variables, and between AASI and latest available follow-up ACR. Receiver operating characteristic (ROC) curves were used to identify the cutoff point for AASI and 24-h pulse pressure that best predicted progression of albuminuria, based on the tradeoff between sensitivity and specificity. 25 The goal of the multivariate analyses was to test the independent association of AASI with follow-up urine albumin excretion after adjustment for other covariates, including office and 24-h pulse pressure. Two types of multivariate analyses were performed: repeated measures mixed linear models, which considered ACR as a continuous variable, and Cox proportional hazards models, which considered albuminuria as a categorical dichotomous variable. In the mixed linear models the AASI quartiles were entered as dummy variables, using the lowest quartile as the reference group. In the Cox models AASI was entered as a dichotomous variable, using the cutoff point identified in ROC curve analysis-this approach was selected because it provided a better fit than the use of AASI quartiles.
Repeated measures mixed linear model analyses were performed with all available ACR measurements from the follow-up visits (one, two, or three measurements, as available) as the dependent variable, using longitudinal random effects methods, and adjusting for baseline ACR values, clustered randomization within provider panels in the parent IDEATel study, and time from baseline to follow-up visits. The following covariates were included: age, gender, ethnicity, randomization status, years since diagnosed with diabetes, current smoking, use of angiotensin-converting enzyme (ACE) inhibitors or angiotensin-receptor blockers (ARB), number of antihypertensive medications, body mass index (BMI), hemoglobin A 1c , HDL-cholesterol, and triglycerides. Office pulse pressure and AASI were also entered in the first model, whereas AASI and 24-h pulse pressure were entered in the second model. Office and ambulatory 24-h pulse pressure were selected as BP covariates for these models because we have found them to be strong predictors progression of albuminuria during follow-up in this population. 15 Collinearity between BP variables was assessed by calculating the tolerance for each of them in the final model. Tolerance values below 0.20 were considered to indicate excessive collinearity. 26 A Cox proportional hazards model analysis was performed to assess whether AASI was independently associated with progression of albuminuria in participants without macroalbuminuria at baseline, after adjusting for clinical covariates and office BP. We adjusted for the following covariates based on biological plausibility and their independent association with follow-up ACR: age, gender, IDEATel randomization group, BMI, baseline urinary albumin-to-creatinine ratio (log-transformed), hemoglobin A 1c , triglycerides, years since diagnosed with diabetes, and number of antihypertensive medications. Office pulse pressure and AASI were the BP variables entered in the first model; 24-h pulse pressure and AASI were entered in the second model. Correctness of the proportional hazards assumption was tested using the Harrell and Lee modification of the Schoenfeld goodness of fit test. 27 All predictor variables were considered fixed at baseline (ie, none of them was treated as time-dependent) in the models we present. Statistical analyses were performed using SPSS, version 13.0 (SPSS, Chicago, IL) and SAS, version 9.0 (SAS Institute Inc., Cary, NC).
Results
Sampling for this study is summarized in Fig. 1 . There were 1180 IDEATel participants with complete baseline data. Of those, 1007 returned for a 1-year follow-up visit, 918 returned for a 2-year follow-up visit, and 744 returned for 3-year follow-up visit. As a result, at least one follow-up ACR was available in 1043 participants. The mean follow-up was 30.4 Ϯ 9 months.
Participant characteristics at baseline are summarized in Table 1 , categorized by quartiles of AASI. As AASI increased, participants were older, more frequently women, had higher office systolic BP and pulse pressure, lower diastolic BP, and were more likely to have microalbuminuria and macroalbuminuria.
In bivariate analyses, baseline values of AASI correlated with baseline values of 24-h pulse pressure (r ϭ 0.44, P Ͻ .001), office pulse pressure (r ϭ 0.29, P Ͻ .001), nocturnal nondipping (r ϭ 0.22, P Ͻ .001), and with the latest available follow-up ACR (r ϭ 0.17, P Ͻ .001).
Among the 957 participants without macroalbuminuria at baseline, 212 experienced progression of albuminuria during follow-up. The proportion of subjects that experienced progression of albuminuria increased from the lowest to the highest AASI quartile ( Fig. 2 ; P for trend ϭ .012). The ROC curve analyses identified the optimal cutoff points to predict progression of albuminuria in this population as AASI Ն0.55 units and 24-h pulse pressure Ն65 mm Hg. Uncontrolled BP at baseline, defined for office and ambulatory measurements as systolic BP Ͼ130 mm Hg or diastolic BP Ͼ80 mm Hg, was not associated with progression of albuminuria (Table 2 ). However, there was a significant association of progression of albuminuria with nocturnal nondipping, and the cutoff points of AASI Ն0.55 units and 24-h pulse pressure Ն65 mm Hg. There were 374 participants with microalbuminuria at baseline. Of them, 94 showed improvement to normoalbuminuria during follow-up. In addition, 86 participants had macroalbuminuria at baseline, and 23 of them showed improvement to microalbuminuria or normoalbuminuria during follow-up. In bivariate comparisons those 117 participants with improvement in albuminuria during follow-up were more likely to have a higher BMI (P ϭ .017). They also exhibited a nonsignificant trend to take a smaller number of antihypertensive medications (P ϭ .06), and to have lower 24-h pulse pressure (P ϭ .07). The AASI was similar in participants with improvement and those without improvement. Table 3 summarizes the findings of the repeated measures mixed model analysis examining the association of baseline characteristics with ACR at follow-up. In the first model, after adjustment for baseline clinical and laboratory characteristics, including office pulse pressure, AASI in the fourth quartile was an independent predictor of follow-up ACR (P ϭ .024). That association did not persist when ABPM 24-h pulse pressure was added as a covariate in the second model. Other variables independently associated with follow-up ACR in this model were BMI, hemoglobin A 1c , triglycerides, duration of diabetes mellitus, and the number of antihypertensive medications. Of note, ABPM was only obtained at the IDEATel baseline visit. Therefore, changes in ABPM at follow-up could not be evaluated. However, we did obtain office BP measurements and medication history at the follow-up visits.
Office BP measurements at follow-up visits did not change significantly within each AASI quartile. In addition, adjustment for changes in ACE inhibitor/ARB use over time did not change our results substantially (results not shown). Those observations suggest that the association of AASI with ACR found in the first multivariate model was not due to increased ACE inhibitor/ARB use or improved BP control in lower AASI quartiles over time.
Cox proportional hazards regression was used to test whether AASI was a predictor of the risk of progression of albuminuria when the latter was assessed within the categories commonly used by clinicians (Table 4 ). In the first multivariate model AASI was an independent predictor of progression of albuminuria; the adjusted hazards ratio (95% CI) for an AASI Ն0.55 units was 1.37 (1.02 to 1.83; P ϭ .035). However, the association between AASI and progression of albuminuria was no longer statistically significant after entering ambulatory pulse pressure into the model. In contrast, 24-h pulse pressure was an independent predictor of the progression of albuminuria in the fully adjusted model (P ϭ .033). Other variables independently associated with progression of albuminuria were male gender, hemoglobin A 1c , and number of antihypertensive medications. Of note, we obtained similar results when 24-h pulse pressure was entered into the Cox model as a dichotomous variable. The hazard ratio (95% CI) for 24-h pulse pressure Ն65 mm Hg was 1.36 (1.02-1.85).
Discussion
To the best of our knowledge, these are the first analyses to be reported that assess the value of AASI in predicting the progression of albuminuria in people with diabetes mellitus. Other investigators have described a cross-sectional association between AASI and albuminuria in younger patients with hypertension and without evidence of cardiovascular disease. 19 Our main finding was that an elevated AASI was associated with higher urine albumin excretion at follow-up after adjusting for several covari- 
FIG. 2.
Percentage of subjects (95% CI) with progression of albuminuria during follow-up, by quartiles of the ambulatory arterial stiffness index (AASI); P for linear trend ϭ .012.
ates, including office pulse pressure, but this association did not persist after additional adjustment for ambulatory pulse pressure. Overall, our results suggest that the association between AASI and progression of albuminuria in this population is significant but relatively modest as compared to 24-h pulse pressure. It should be noted that the clinical significance of AASI, and the prognostic information it may provide are Table 3 . Results of repeated measures mixed linear models for 1043 participants with one-year (n ϭ 1007), two-year (n ϭ 918), and three-year (nϭ 744) follow-up urine albumin-to-creatinine ratio as the outcome AASI ϭ ambulatory arterial stiffness index; ACR ϭ albumin-to-creatinine ratio. All covariates are listed in the not yet fully understood. The AASI has been proposed as a more dynamic estimate of arterial stiffness than pulse pressure. Pulse pressure only reflects the static difference between systolic and diastolic BP, without taking into consideration the variability in the relationship between them. 17 Existing data suggest that AASI and pulse pressure reflect different characteristics of the arterial system, and thus provide different information. For example, in the study by Dolan et al, 18 AASI performed better than pulse pressure in predicting fatal strokes, whereas pulse pressure performed better than AASI in predicting cardiac deaths. Other investigators interpreted those findings as a suggestion that AASI may be a good measurement of the relationship between the pulsatile and steady components of BP. 28 Our findings appear to confirm the impression that AASI and pulse pressure, although significantly correlated with each other, may contribute information about different domains, with ambulatory pulse pressure performing better in predicting an increase in urine albumin excretion in this elderly cohort. However, it is possible that AASI may be a better indicator of arterial dysfunction in younger populations. 17 The aforementioned cross-sectional study by Leoncini et al 19 was performed in a younger, healthier cohort. Thus, the value of AASI to identify patients at higher risk of developing albuminuria should also be evaluated in younger patients with diabetes.
The role of nocturnal hypertension as a predictor of albuminuria has been well described in people with type 1 diabetes. 14 We have also found a significant bivariate association between nocturnal nondipping and progression of albuminuria. The absence of an independent association in multivariate models in our study is probably due to the significant correlation between nondipping and 24-h pulse pressure. Nocturnal nondipping remains a relevant clinical predictor of albuminuria in people with diabetes.
This study has several limitations. First, we measured albumin urinary excretion using a single-spot urine sample. Although a 24-h urine collection, or three measurements instead of one, may provide a more accurate measurement of renal albumin excretion, assessment of albuminuria in a spot urine sample has been accepted as an accurate estimate, 29 -32 and a feasible alternative in large studies. Furthermore, there is no reason to expect that misclassification of albuminuria caused by our measurement procedure would be differential with respect to the predictor variables. Second, as previously noted, our sample was composed of older subjects, with long-standing diabetes mellitus and prevalent end-organ damage at the time of enrollment. Our findings may not be applicable to younger patients. Third, the IDEATel baseline examination did not include an assessment of renal function, such as a serum creatinine measurement. Patients with advanced renal failure were excluded from enrollment, but we do not know whether the addition of a serum creatinine measurement would have changed significantly our results. Finally, we do not have any other measurements of arterial stiffness (eg, applanation tonometry) to further validate our findings in this population.
The strengths of this study include a longitudinal design that examines the temporal relationship between exposures (pulse pressure, AASI) and the outcome (changes in albuminuria). This sample was large, well-characterized, elderly, and multiethnic, with an adequate representation of women. Information regarding pertinent covariates, including a detailed medication inventory, and comprehensive laboratory and anthropometric measurements was available. Moreover, ABPM was performed using a wellvalidated methodology.
In conclusion, the association between AASI and progression of albuminuria in this cohort of elderly patients with diabetes is relatively modest, and AASI does not add significantly to the predictive information provided by 24-h pulse pressure. The value of AASI to predict progression of albuminuria should be further examined in younger populations with diabetes mellitus.
